Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer.
Satoshi KobayashiMotoko SuzukiMakoto UenoYuta MarukiNaohiro OkanoAkiko TodakaMasato OzakaKunihiro TsujiKazuhiko ShiojiKeitaro DoiYasushi KojimaHidetaka TsumuraKazunari TanakaHajime HiguchiKen KawabeHiroshi ImaokaTatsuya YamashitaHaruo MiwaHiroaki NaganoShiho ArimaHideyuki HayashiAtsushi NaganumaHironori YamaguchiTerumasa HisanoKumiko UmemotoShuji IshiiKoji NakashimaRei SuzukiYohei KitanoToshihiro MisumiJunji FuruseHiroshi IshiiPublished in: The oncologist (2022)
GnP is more efficacious than Gem in patients aged ≥76 years with uPC despite demonstrating a higher incidence of severe adverse events.